Personal tools
You are here: Home → Molecular targeting of stem cells for therapy: Novel pathways for induced reprogramming and transdifferentiation
Navigation
Log in


Forgot your password?
 
Document Actions

Molecular targeting of stem cells for therapy: Novel pathways for induced reprogramming and transdifferentiation

What Meeting
When 16-07-2010
from 11:00 to 18:00
Where ENS LYON
Contact Name Brian B. RUDKIN
Contact Email Brian.Rudkin@ens-lyon.fr
Add event to calendar vCal (Windows, Linux)
iCal (Mac OS X)
by Sebastien Lebreton — last modified 06-07-2010 17:54

Speaker: Frank EDENHOFFER, PhD

Head, Stem Cell Engineering Group

Institute of Reconstructive Neurobiology

University of Bonn ‐ Medical Center Germany

Selected references
Patsch, C., M. Peitz, D.M. Otte, D. Kesseler, J. Jungverdorben, F.T. Wunderlich, O. Brustle, A. Zimmer & F.
Edenhofer. (2010). Engineering cell‐permeant FLP recombinase for tightly controlled inducible and reversible overexpression in embryonic stem cells. Stem Cells 28:894‐902 (Mar 23 [Epub ahead of print]).

Bosnali, M & F. Edenhofer. Generation of transducible transcription factors Oct4 and Sox2. (2008) Biol. Chem. 389:851‐861.

Nolden, L., F. Edenhofer, S. Haupt, F. T. Wunderlich, H. Siemen & O. Brüstle. Site specific recombination in human ES cells induced by cell permeable Cre recombinase. (2006) Nature Methods 3:461‐467

Host : Brian B. RUDKIN (bbrudkin@ens‐lyon.fr)
*46, allée d’Italie, 69007 Lyon

Related content
« February 2012 »
Su Mo Tu We Th Fr Sa
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29